News Dec 19, 2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
News Dec 18, 2023 UPM Biomedicals chooses the Basel Area as European bridgehead UPM Biomedicals is opening a lab on the Main Campus of Switzerland Innovation Park Basel Area. The Finnish company specializes in nanofibrillar c...
News Dec 13, 2023 Macrogen establishes foothold in Basel Macrogen Europe is set to move into the Novartis Campus of Switzerland Innovation Park Basel Area. As with its parent company, the South Korean b...
News Dec 12, 2023 PharmaBiome and Ferring agree cooperation PharmaBiome and the biopharmaceutical firm Ferring from the canton of Vaud will in future each jointly develop and manufacture specific bacterial...
News Dec 11, 2023 Artbio and Scailyte making headlines in Basel The biotech company Scailyte has raised 8 million US dollars as part of a Series A financing round. For its part, Artbio has raised as much as 90...
News Dec 06, 2023 Philochem launches clinical trial for tumor imaging Philochem and Blue Earth Diagnostics have examined their first three patients as part of a Phase 1 clinical trial. The trial aims to develop a sm...
News Dec 04, 2023 Cradle raises 24 million US dollars Cradle has raised 24 million dollars in a Series A funding round. The biotech startup has developed a platform that enables biologists to design ...
News Nov 29, 2023 Mechanically reprogrammed cells can accelerate wound healing A group of researchers at the Paul Scherrer Institute have mechanically reprogrammed connective tissue cells to make a type of stem cells. This a...
News Nov 27, 2023 Boehringer Ingelheim acquires T3 Pharma Boehringer Ingelheim has acquired T3 Pharma, which is based in the Switzerland Innovation Park Basel Area, for an amount of up to 450 million Swi...
News Nov 21, 2023 CRISPR Therapeutics and Vertex awarded historic authorization The two partners CRISPR Therapeutics and Vertex have secured the world’s first approval for a genome editing therapy based on what are known as g...
News Nov 15, 2023 Nouscom secures 67.5 million euros in financing Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based company intends to use the funds to advance the clinical dev...
News Nov 06, 2023 Vaud-based LAGOSTA and global giant Merck collaborate on chitosan distribution Biotech company LAGOSTA has announced a collaboration with Merck. The partnership aims to facilitate the distribution of LAGOSTA's superior chito...
News Nov 06, 2023 Investors stump up 3.7 million Swiss francs in Onena Medicines Onena Medicines has secured investment of 3.7 million Swiss francs. The portfolio company of the biotech start-up incubator BaseLaunch will there...
News Nov 06, 2023 Abionic and Lascco partner with Fapon for sepsis diagnosis in China Biopôle companies Abionic and Lascco team up with Fapon to harness a groundbreaking biomarker for sepsis detection, enhancing early diagnosis cap...
News Nov 03, 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
News Nov 01, 2023 Palto Therapeutics receives 150,000 Swiss francs from Venture Kick Palto Therapeutics has won the third stage of the Venture Kick promotional funding program. As such, the company now stands to benefit from 150,0...
News Oct 31, 2023 Debiopharm invests CHF 30 million in Valais amidst workforce surge Debiopharm Research & Manufacturing has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150...
News Oct 20, 2023 Lonza expands to manufacture Vaxcyte’s pneumococcal conjugate vaccine Lonza and US clinical-stage vaccine innovation company Vaxcyte have announced an expansion in their partnership to establish a global commercial ...